Governance Genmab A/S Nasdaq

GMAB

US3723032062

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-09-03 EDT			5-day change	1st Jan Change
34.41 ^USD	+0.57%		+0.91%	+11.72%

09-03	Handelsbanken Adds Xvivo and Vimian as Sector Favorites, Drops Danish Duo	FW
09-01	Deutsche Bank raises price target for Genmab to 2,500 Danish kroner, reiterates buy	FW

Executive Committee: Genmab A/S

Manager

Positions heldSince

Jan van de Winkel

65 year

Chief Executive Officer	2010-05-31
Founder	1998-06-10
President	2010-05-31

Rayne Waller

Chief Tech/Sci/R&D Officer

2024-08-15

Christopher Cozic

48 year

Human Resources Officer

2016-12-31

Tahamtan Ahmadi

53 year

Chief Tech/Sci/R&D Officer

2021-01-31

Andrew Carlsen

Investor Relations Contact

Anthony Pagano

48 year

Director of Finance/CFO

2020-02-29

Gregory David Emil Mueller

55 year

General Counsel

2025-06-30

Composition of the Board of Directors: Genmab A/S

Director

CommitteesSince

Deirdre Connelly

65 year

Compensation Committee	2020-03-25
Governance Committee Chair
Nominating Committee Chair
Audit Committee	2020-03-25
Executive Committee
Governance Committee	2024-09-11
Compensation Committee Chair	2024-09-11
Finance Committee	2020-03-25
Nominating Committee	2024-09-11

Anders Gersel Pedersen

75 year

Compensation Committee Chair	2019-12-31
Governance Committee Chair
Nominating Committee Chair	2019-12-31
Audit Committee	2019-12-31
Finance Committee	2013-12-31

Pernille Lyngvold Erenbjerg

58 year

Governance Committee	2014-12-31
Nominating Committee	2014-12-31
Audit Committee Chair	2022-04-26
Finance Committee Chair	2014-12-31

Rolf K. Hoffmann

66 year

Audit Committee	2016-12-31
Finance Committee	2016-12-31
Compensation Committee	2023-06-14
Nominating Committee	2023-06-14

Elizabeth O'Farrell

62 year

Audit Committee	2022-03-28
Compensation Committee Chair
Audit Committee Chair	2026-01-29
Finance Committee	2022-03-28

Paolo Augusto Paoletti

75 year

Compensation Committee

Martin Schultz

51 year

Director/Board Member

2021-12-31

Michael Kavanagh

Director/Board Member

2025-03-11

Mijke Zachariasse

53 year

Director/Board Member

2019-03-28

Former Officers and Directors: Genmab A/S

Insider

Positions held

SinceUntil

Birgitte Stephensen

General Counsel

2025-06-30

Anthony Mancini

Chief Operating Officer

2020-03-22

2024-08-15

Takahiro Hamatani

Director/Board Member

2021-12-31

Jonathan Peacock

Director/Board Member	2020-03-25	2021-11-14
Independent Dir/Board Member	2020-03-25	2021-11-14

Suba Krishnan

Corporate Officer/Principal

2019-08-31

2020-10-31

Michael K. Bauer

Chief Tech/Sci/R&D Officer	-	2020-09-30
Corporate Officer/Principal	2012-07-31	-

Mats Gunnar Pettersson

Director/Board Member	2013-04-16	-
Chairman	2013-04-16	2020-03-25
Independent Dir/Board Member	2013-04-16	2020-03-25

David Andrew Eatwell

Director of Finance/CFO

2008-06-01

2020-02-28

Richard Gordon Hibbert

Director/Board Member

2015-12-31

2019-03-28

Rachel Curtis Gravesen

Investor Relations Contact	2011-04-30	2019-03-10
Public Communications Contact	2011-04-30	2019-03-10

Rima Bawarsh Nassar

Director/Board Member

2018-12-31

Burt Malkiel

Director/Board Member	2010-03-31	2018-05-31
Independent Dir/Board Member	2006-12-31	2018-05-31

Paul W. H. I. Parren

Chief Tech/Sci/R&D Officer

2001-08-31

2017-07-31

Steen Lisby

Chief Tech/Sci/R&D Officer

2007-12-31

2016-12-31

Peter Storm Kristensen

Director/Board Member

2015-12-31

Hans Henrik Munch-Jensen

Director/Board Member	2009-03-25	2014-12-31
Independent Dir/Board Member	2006-12-31	2014-12-31

Karsten Havkrog Pedersen

Director/Board Member	2002-02-28	2013-03-31
Independent Dir/Board Member	2002-02-28	2013-03-31

Michael Blair Widmer

Director/Board Member	2012-03-27	2013-03-31
Chairman	2002-02-28	2012-04-26
Independent Dir/Board Member	2002-02-28	2013-03-31

Daniel John Bruno

Comptroller/Controller/Auditor	2007-12-31	2013-03-31
Director/Board Member	2010-06-24	2013-03-31
Comptroller/Controller/Auditor	2015-12-31	-
Director/Board Member	2015-12-31	2020-07-31

Antonius Theodorus M Wilderbeek

Director/Board Member	2011-04-05	2013-03-31
Independent Dir/Board Member	2011-04-05	2013-03-31

Patrick van Berkel

Chief Tech/Sci/R&D Officer

2002-12-31

2011-12-31

Helle Husted

Investor Relations Contact	2011-04-27	2011-04-30
Public Communications Contact	-	2011-04-27

Joris Wilms

Corporate Officer/Principal

2008-09-30

2010-11-30

Eva Ehrnrooth

Chief Tech/Sci/R&D Officer

2008-05-31

2010-01-31

Lisa N. Drakeman

Founder	1998-12-31	2009-12-31
President	1998-12-31	2009-12-31

Ernst H. Schweizer

Director/Board Member

2009-03-25

2009-04-14

Barry Littlejohns

Chief Operating Officer

2010-05-27

Bo Kruse

Comptroller/Controller/Auditor	1999-12-31	2004-12-31
Director of Finance/CFO	2004-12-31	2008-06-01

Claus Juan Møller-San Pedro

Chief Operating Officer

1998-12-31

2007-12-31

Irwin Lerner

Director/Board Member

2007-01-30

Hanne Jensen

Corporate Officer/Principal

1998-12-31

Annarie Lyles

Corporate Officer/Principal

2010-05-27

Christina Hahner

Chief Administrative Officer	2004-12-31	-
Public Communications Contact	2004-12-31	-

Joseph Fred Yospe

Comptroller/Controller/Auditor

2002-08-31

2004-08-31

Nedjad Losic

Director/Board Member	2010-06-24	-
Corporate Officer/Principal	2003-12-31	-

Michael Wolff Jensen

Director of Finance/CFO

1999-12-31

2002-12-31

Tom Vink

Director/Board Member	2010-06-24	-
Corporate Officer/Principal	2001-12-31	-

Jorgen Petersen

Chief Tech/Sci/R&D Officer

2001-12-31

Rikke Glahn Ren

Corporate Officer/Principal

2000-12-31

Ole Baadsgaard

Chief Tech/Sci/R&D Officer	2010-05-27	-
Corporate Officer/Principal	2010-05-27	2010-05-27

Donald Lee Drakeman

Founder

1998-06-10

Florian Schönharting

Founder

1998-06-10

Dorrit T. Andersen

General Counsel

Torben Lund-Hansen

Corporate Officer/Principal

Francesco de Rubertis

Director/Board Member

Linda Basse

Chief Tech/Sci/R&D Officer

Flemming Heise Pedersen

Director/Board Member

Eva Steiness

Chairman

Jesper Zeuthen

Chairman

Scott Cenci

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	16
Female	4

Of which Executive Committee

Male	7
Female	0

Of which Directors

Male	6
Female	3

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.4%); - income from sales of products (10.7%); - other (5.9%): primarily income from partnership agreement. Net sales are distributed geographically as follows: Denmark (89.4%), the United States (4.9%) and Japan (5.7%).

Employees

3,119

Sector

Biotechnology & Medical Research

Calendar

11-04 Earnings release - Q3 2026

More about the company